Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

Anti-Human VSIG4/CRIg Antibody (SAA0775), PE

Catalog #:   FHK26822 Specific References (34) DATASHEET
Host species: Mouse
Isotype: IgG2a
Applications: ELISA, FCM
Accession: Q9Y279
Overview

Catalog No.

FHK26822

Species reactivity

Human

Host species

Mouse

Isotype

IgG2a

Clonality

Monoclonal

Conjugation

PE

Target

Protein Z39Ig, CRIg, V-set and immunoglobulin domain-containing protein 4, VSIG4, Z39IG

Concentration

0.5 mg/ml

Endotoxin level

Please contact with the lab for this information.

Accession

Q9Y279

Applications

ELISA, FCM

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.2% BSA, 0.05% Proclin 300.

Stability and Storage

Store at 4°C for 12 months. Protect from light. Do not freeze.

Clone ID

SAA0775

Data Image
References

VSIG4 Promotes Tumour-Associated Macrophage M2 Polarization and Immune Escape in Colorectal Cancer via Fatty Acid Oxidation Pathway., PMID:40405491

A serum biomarker panel and miniarray detection system for tracking disease activity and flare risk in lupus nephritis., PMID:40375995

VSIG4-Expressing Macrophages Contribute to Antiparasitic and Antimetastatic Responses in the Peritoneal Cavity., PMID:40346775

Antibodies Targeting Human or Mouse VSIG4 Repolarize Tumor-Associated Macrophages Providing the Potential of Potent and Specific Clinical Anti-Tumor Response Induced across Multiple Cancer Types., PMID:38892347

V-Set and immunoglobulin domain containing (VSIG) proteins as emerging immune checkpoint targets for cancer immunotherapy., PMID:36189222

Neutrophils Require Activation to Express Functional Cell-Surface Complement Receptor Immunoglobulin., PMID:35317169

VISTA Stimulation of VSIG4-Positive Macrophages Strongly Suppresses T Cell Proliferation via Excessive Nitric Oxide Production in Sepsis., PMID:34433706

Extracellular Histone H3 Induces Pyroptosis During Sepsis and May Act Through NOD2 and VSIG4/NLRP3 Pathways., PMID:32432055

Human Dendritic Cells Express the Complement Receptor Immunoglobulin Which Regulates T Cell Responses., PMID:31921153

CRIg plays an essential role in intravascular clearance of bloodborne parasites by interacting with complement., PMID:31723045

NIRF-Molecular Imaging with Synovial Macrophages-Targeting Vsig4 Nanobody for Disease Monitoring in a Mouse Model of Arthritis., PMID:31288389

VSIG4 mediates transcriptional inhibition of Nlrp3 and Il-1β in macrophages., PMID:30662948

V-set and Ig domain-containing 4 (VSIG4)-expressing hepatic F4/80+ cells regulate oral antigen-specific responses in mouse., PMID:29235119

Structural evaluation of a nanobody targeting complement receptor Vsig4 and its cross reactivity., PMID:27889311

Extracellular stimulation of VSIG4/complement receptor Ig suppresses intracellular bacterial infection by inducing autophagy., PMID:27440002

Molecular Imaging with Kupffer Cell-Targeting Nanobodies for Diagnosis and Prognosis in Mouse Models of Liver Pathogenesis., PMID:27339464

Complement receptor immunoglobulin: a control point in infection and immunity, inflammation and cancer., PMID:27045607

Complement receptor of the immunoglobulin superfamily reduces murine lupus nephritis and cutaneous disease., PMID:25988858

Endogenous VSIG4 negatively regulates the helper T cell-mediated antibody response., PMID:25929804

Monitoring liver macrophages using nanobodies targeting Vsig4: concanavalin A induced acute hepatitis as paradigm., PMID:25440182

A novel CRIg-targeted complement inhibitor protects cells from complement damage., PMID:25114177

Molecular imaging with macrophage CRIg-targeting nanobodies for early and preclinical diagnosis in a mouse model of rheumatoid arthritis., PMID:24686780

Protective role of V-set and immunoglobulin domain-containing 4 expressed on kupffer cells during immune-mediated liver injury by inducing tolerance of liver T- and natural killer T-cells., PMID:22711680

Down-regulation of Z39Ig on macrophages by IFN-gamma in patients with chronic HBV infection., PMID:20399148

A novel inhibitor of the alternative pathway of complement attenuates intestinal ischemia/reperfusion-induced injury., PMID:19691988

Expansion of a unique macrophage subset in rheumatoid arthritis synovial lining layer., PMID:18727628

Deficiency of decay-accelerating factor and complement receptor 1-related gene/protein y on murine platelets leads to complement-dependent clearance by the macrophage phagocytic receptor CRIg., PMID:18524992

A novel inhibitor of the alternative pathway of complement reverses inflammation and bone destruction in experimental arthritis., PMID:17548523

VSIG4, a B7 family-related protein, is a negative regulator of T cell activation., PMID:17016562

To be or not to be B7., PMID:17016555

Z39Ig is expressed on macrophages and may mediate inflammatory reactions in arthritis and atherosclerosis., PMID:16882875

Characterization of monoclonal antibody specific to the Z39Ig protein, a member of immunoglobulin superfamily., PMID:16009265

Z39Ig is co-expressed with activated macrophage genes., PMID:11997108

Cloning of Z39Ig, a novel gene with immunoglobulin-like domains located on human chromosome X., PMID:11004523

Datasheet
$ 292
Product specifications
50 T 292 100 T 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human VSIG4/CRIg Antibody (SAA0775), PE [FHK26822]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only